An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic
Journal of Clinical Investigation (2007) - Comment
pubmed: 18060038  doi: 10.1172/jci32373  issn: 0021-9738 

Ariel Fernández, Angela Sanguino, Zhenghong Peng, Eylem Ozturk, Jianping Chen, Alejandro Crespo, Sarah Wulf, Aleksander Shavrin, Chaoping Qin, Jianpeng Ma, Jonathan Trent, Yvonne Lin, Hee-Dong Han, Lingegowda S. Mangala, James A. Bankson, Juri Gelovani, Allen Samarel, William Bornmann, Anil K. Sood, Gabriel Lopez-Berestein